AI genomics and precision medicine — the machine learning algorithms interpreting whole genome sequencing, identifying disease-associated variants, predicting drug response, and enabling personalized treatment decisions — represents the longest-term but potentially most transformative AI healthcare application, with the Artificial Intelligence in Healthcare Market reflecting...

Atopic dermatitis biomarkers and precision medicine — the development of serum, genetic, and microbiome biomarkers enabling AD patient stratification, treatment selection, and treatment response prediction — represents the AD field's movement toward precision dermatology, with the Atopic Dermatitis Market reflecting biomarker development as a clinical and commercial market driver....

To understand the complexity of this industry, one must look at the Circulating Tumor Cell Market segment breakdown, which typically categorizes the market by technology, application, and end-user. The technology segment is divided into enrichment methods (like immunomagnetic or size-based) and detection methods (such as PCR or immunocytochemistry). Currently, immunomagnetic enrichment remains...

The High Mobility Group Protein B1 Market is driven by increasing prevalence of chronic diseases, rising demand for biomarker-based diagnostics, and continuous advancements in molecular biology research. HMGB1 plays a crucial role in regulating immune responses, making it a significant target in therapeutic research. Growing incidence of cancer, sepsis, autoimmune disorders, and...

According to the latest report published by Data Bridge Market Research, the Diagnostic Imaging Equipment Market  CAGR Value The global diagnostic imaging equipment market size was valued at USD 53.60 billion in 2024 and is expected to reach USD 78.59 billion by 2032, at a CAGR of 4.90% during the forecast period All the statistical data including facts and figures that are...

The In Vitro Diagnostic Market continues to expand at a substantial pace as global demand for accurate, rapid, and decentralized disease detection solutions rises steadily across clinical laboratories, hospitals, and point-of-care settings. In vitro diagnostics encompass a vast array of tests performed on blood, tissue, urine, and other biological specimens to detect infections, monitor chronic...

A robust clinical trial ecosystem is fundamental to the growth of the India Antibodies Market. India offers a diverse patient population and a large network of clinical research organizations (CROs) capable of executing complex trials for antibody-based products. This environment allows companies to gather necessary data on efficacy and safety, which is a prerequisite for both local and...

Lutetium 177 Market Surges with Precision Cancer Therapies and Nuclear Medicine Innovations     According to a new report from Intel Market Research, the global Lutetium-177 (Lu-177) market was valued at USD 1,564 million in 2023 and is projected to reach USD 6,376.28 million by 2032, growing at a robust CAGR of 16.90% during the forecast period (2025–2032). This exceptional...

The Monoclonal Antibody Therapy Market is witnessing rapid expansion as healthcare providers increasingly adopt targeted therapies to improve patient outcomes. Monoclonal Antibody Therapy Market research highlights the ability of monoclonal antibodies to selectively bind disease-causing antigens, minimizing damage to healthy tissue. Biopharmaceutical companies are investing heavily in R&D...

The global industry was valued at US$ 2.2 Bn in 2022 and is projected to grow at a CAGR of 7.7% from 2023 to 2031, reaching more than US$ 4.3 Bn by the end of 2031. The nanoparticle contract manufacturing market is witnessing significant growth as pharmaceutical, biotechnology, and life sciences companies increasingly outsource the production of complex nanoparticle-based formulations. Rising...

Chronic disease prevention represents the most ambitious and potentially most impactful application of nutrigenomics, with the vision that genetic understanding of individual variation in dietary risk factor response could enable precision dietary interventions targeting the specific nutritional factors that matter most for each individual's genetic profile, reducing the burden of...

Artificial intelligence and machine learning in precision medicine — the analytical engines enabling pattern recognition in multi-dimensional omics datasets, imaging data, clinical records, and real-world evidence that human cognitive capacity cannot process — represent the computational foundation that makes precision medicine scalable, with the Precision Medicine Market...